YKL131W Antibody

What is YKL131W and why is an antibody against it valuable for yeast research?

YKL131W is a systematic name for a gene in Saccharomyces cerevisiae (baker's yeast), following the yeast genome nomenclature system. Antibodies against this protein are valuable research tools for studying protein expression, localization, and function in yeast cellular processes. Unlike general yeast antibodies, a specific YKL131W antibody allows for precise targeting of this particular protein, enabling researchers to investigate its role in cellular pathways, protein-protein interactions, and responses to environmental conditions. Antibodies targeting specific yeast proteins like YKL131W are essential for techniques including western blotting, immunoprecipitation, chromatin immunoprecipitation, and immunofluorescence microscopy in yeast model systems .

How do I validate the specificity of a YKL131W antibody before using it in my experiments?

Antibody validation is critical for ensuring experimental reliability. For YKL131W antibody, validation should include:

• Western blot analysis using wild-type yeast lysate versus a YKL131W knockout strain, expecting signal only in the wild-type

• Peptide competition assay where pre-incubation with the immunizing peptide should abolish signal

• Testing cross-reactivity against related yeast proteins

• Immunoprecipitation followed by mass spectrometry to confirm target specificity

• Immunofluorescence microscopy comparing wild-type and knockout strains

The validation process should produce quantifiable results that demonstrate specificity, such as a single band of the expected molecular weight in western blots and absence of significant cross-reactivity with other yeast proteins. For proper validation, multiple methodologies should be employed rather than relying on a single technique to confirm specificity .

What are the key differences between polyclonal and monoclonal antibodies for YKL131W detection?

The choice between polyclonal and monoclonal antibodies significantly impacts experimental outcomes:

For yeast protein detection, polyclonal antibodies often provide higher sensitivity due to their ability to recognize multiple epitopes, making them preferable for proteins with low expression levels. Monoclonal antibodies, similar to the characterized neutralizing antibodies like CSW1-1805, offer precision in targeting specific epitopes and are ideal when discriminating between closely related proteins is necessary .

How can I optimize western blot protocols when using YKL131W antibody for yeast protein detection?

Optimizing western blots for yeast proteins requires several specific considerations:

• Yeast cell lysis: Use glass bead disruption or specialized yeast lysis buffers containing protease inhibitors to prevent protein degradation

• Sample preparation: Include a 100°C heating step with SDS sample buffer to ensure complete protein denaturation

• Gel percentage selection: Select based on the molecular weight of YKL131W (typically 10-12% for medium-sized yeast proteins)

• Transfer conditions: Optimize transfer time and voltage based on protein size (typically 100V for 1 hour for medium-sized proteins)

• Blocking: Use 5% BSA instead of milk for phospho-specific antibodies or 5% milk for general detection

• Antibody dilution: Start with 1:1000 dilution and adjust based on signal intensity

• Detection: Choose chemiluminescence for sensitive detection or fluorescent secondary antibodies for quantitative analysis

When troubleshooting, systematically modify one variable at a time and document outcomes. The yeast cell wall presents unique challenges that may require optimization beyond standard mammalian protocols. Confirmation through knockout controls is essential to validate specificity in the yeast cellular context .

What are the best protocols for immunoprecipitation of YKL131W from yeast lysates?

Effective immunoprecipitation of yeast proteins requires careful attention to lysis conditions and antibody-bead coupling:

• Prepare yeast lysate:

  • Harvest mid-log phase cells (OD600 = 0.6-0.8)

  • Lyse cells using glass beads in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, and protease inhibitors

  • Clear lysate by centrifugation (14,000 × g, 15 min, 4°C)

• Pre-clear lysate with protein A/G beads for 1 hour at 4°C

• Antibody coupling:

  • Option A: Direct method - Add 2-5 μg YKL131W antibody to 500 μg protein lysate and incubate overnight at 4°C, then add protein A/G beads

  • Option B: Pre-coupling method - Conjugate antibody to beads first, then add to lysate

• Wash beads 4-5 times with lysis buffer and elute proteins with SDS sample buffer or low pH glycine buffer

The choice between direct and pre-coupling methods depends on antibody characteristics. For weaker binding antibodies, the pre-coupling method typically yields better results. Validation should include both positive (input lysate) and negative (IgG control) samples .

How can I use YKL131W antibody for immunofluorescence microscopy in yeast cells?

Immunofluorescence in yeast requires specific adaptations due to the yeast cell wall:

• Cell preparation:

  • Fix mid-log phase yeast cells with 4% formaldehyde for 1 hour at room temperature

  • Wash cells in PBS containing 1.2 M sorbitol (PBS-S)

  • Digest cell wall with zymolyase (100 μg/ml) in PBS-S with 0.1% β-mercaptoethanol for 20-30 minutes at 30°C

  • Monitor spheroplasting efficiency microscopically

• Immunostaining:

  • Permeabilize spheroplasts with 0.1% Triton X-100 for 10 minutes

  • Block with 1% BSA in PBS for 30 minutes

  • Incubate with primary YKL131W antibody (1:100-1:500 dilution) overnight at 4°C

  • Wash 3 times with PBS

  • Incubate with fluorophore-conjugated secondary antibody (1:1000) for 1 hour at room temperature

  • Counterstain nucleus with DAPI (1 μg/ml)

  • Mount slides with antifade mounting medium

• Controls:

  • Include YKL131W deletion strain as negative control

  • Use secondary antibody-only sample to assess background fluorescence

Unlike mammalian cells, achieving consistent spheroplasting while maintaining cellular morphology is crucial for successful yeast immunofluorescence. Cell wall digestion must be optimized for each strain and growth condition to prevent over-digestion (cell lysis) or under-digestion (antibody inaccessibility) .

Why might I be experiencing high background in western blots using YKL131W antibody?

High background in yeast western blots can result from several factors:

• Non-specific binding: Yeast lysates contain numerous proteins that may cross-react with antibodies. Optimize blocking conditions by testing different blockers (milk, BSA, casein) and concentrations (3-5%).

• Insufficient washing: Increase washing time (15 minutes per wash) and number of washes (4-5 times) with TBST (TBS + 0.1% Tween-20).

• Antibody concentration: Dilute primary antibody further (try 1:2000 or 1:5000 instead of 1:1000).

• Secondary antibody issues: Try a different secondary antibody or increase its dilution (1:10,000 or higher).

• Membrane handling: Avoid touching membrane with bare hands; use forceps and gloves.

• Sample preparation: Ensure complete cell lysis and proper protein denaturation; consider adding additional protease inhibitors.

• Detection system sensitivity: Reduce exposure time or switch to a less sensitive detection method if using enhanced chemiluminescence (ECL).

When troubleshooting, implement one change at a time and document results systematically. For particularly challenging antibodies, consider using alternative blocking agents such as fish gelatin or commercially available blocking buffers specifically formulated for yeast applications .

How can I improve signal intensity when the YKL131W protein is expressed at low levels?

Detecting low-abundance yeast proteins requires enhanced sensitivity approaches:

• Sample enrichment:

  • Increase starting material (use 2-3× more yeast cells)

  • Perform TCA precipitation to concentrate proteins

  • Consider subcellular fractionation if the protein localizes to a specific compartment

• Detection optimization:

  • Use high-sensitivity ECL substrates (femtogram detection range)

  • Switch to fluorescent detection systems with signal accumulation capabilities

  • Consider biotin-streptavidin amplification systems

• Antibody enhancement:

  • Extend primary antibody incubation time (overnight at 4°C)

  • Try signal amplification methods like tyramide signal amplification (TSA)

  • Use detection systems with multiple secondary antibodies per primary antibody

• Technical considerations:

  • Use PVDF membranes instead of nitrocellulose for higher protein binding capacity

  • Reduce transfer buffer methanol content to improve high molecular weight protein transfer

  • Optimize gel percentage for better resolution of target protein

• Expression system modifications:

  • Consider epitope tagging the endogenous YKL131W gene if antibody detection remains challenging

  • Use copper or galactose-inducible promoters for controlled overexpression studies

A systematic approach combining multiple strategies typically yields the best results for detecting low-abundance yeast proteins. Document each modification to establish an optimized protocol for future experiments .

What strategies can I use when YKL131W antibody shows cross-reactivity with other yeast proteins?

Cross-reactivity issues can be addressed through several approaches:

• Antibody purification:

  • Perform affinity purification using the immunizing peptide

  • Use protein A/G columns to purify IgG fraction

  • Consider subtraction methods using lysates from YKL131W knockout strains

• Experimental modifications:

  • Increase antibody dilution to reduce non-specific binding

  • Modify blocking conditions (try 5% BSA with 1% normal serum from secondary antibody species)

  • Add competing peptides to block specific cross-reactivities

• Analytical approaches:

  • Run parallel blots with YKL131W knockout lysates

  • Perform 2D gel electrophoresis to better separate cross-reacting proteins

  • Include molecular weight markers close to your protein of interest

• Alternative detection methods:

  • Use epitope tagging strategies (HA, FLAG, etc.) if antibody specificity cannot be improved

  • Consider mass spectrometry-based approaches for protein identification

  • Implement multiplexed detection with a second antibody to confirm identity

For yeast systems specifically, cross-reactivity is often observed with highly conserved proteins. Using antibodies raised against unique, less-conserved regions of YKL131W can improve specificity. Testing the antibody against lysates from related yeast species can also help identify potential cross-reactivities .

How can I use YKL131W antibody for chromatin immunoprecipitation (ChIP) studies in yeast?

ChIP protocols for yeast proteins require specific adaptations:

• Chromatin preparation:

  • Cross-link yeast cells with 1% formaldehyde for 15-20 minutes at room temperature

  • Quench crosslinking with 125 mM glycine for 5 minutes

  • Lyse cells using glass beads in lysis buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors)

  • Fragment chromatin by sonication to 200-500 bp fragments

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads for 1 hour at 4°C

  • Incubate cleared chromatin with YKL131W antibody overnight at 4°C

  • Add protein A/G beads and incubate for 2-3 hours at 4°C

  • Wash beads progressively with increasingly stringent buffers

• DNA recovery and analysis:

  • Reverse crosslinks by heating at 65°C overnight

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol/chloroform extraction or commercial kits

  • Analyze by qPCR or next-generation sequencing

For transcription factors or chromatin-associated proteins, epitope accessibility can be a challenge. Optimizing crosslinking time is crucial - excessive crosslinking can mask epitopes, while insufficient crosslinking leads to poor recovery. The fragmentation step is particularly critical in yeast ChIP experiments, as yeast genomes are more compact than mammalian genomes .

What are the considerations for using YKL131W antibody in co-immunoprecipitation to study protein-protein interactions?

Co-immunoprecipitation (co-IP) for yeast protein interactions requires careful buffer optimization:

• Lysis buffer selection:

  • For stable interactions: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1-0.5% NP-40, protease inhibitors

  • For weak/transient interactions: Reduce salt (100 mM NaCl) and detergent (0.1% NP-40)

  • For membrane proteins: Include 1% digitonin or 0.5% CHAPS instead of NP-40

  • For phosphorylation-dependent interactions: Add phosphatase inhibitors

• Experimental design:

  • Perform reciprocal co-IPs when possible (IP with antibodies against both interaction partners)

  • Include appropriate controls (IgG control, deletion strain lysate)

  • Consider crosslinking (e.g., DSP, formaldehyde) for transient interactions

  • Optimize antibody concentration (typically 2-5 μg per mg of protein lysate)

• Detection strategies:

  • Western blot with antibodies against potential interacting partners

  • Mass spectrometry for unbiased identification of interaction partners

  • Targeted proteomics approaches for complex samples

• Validation approaches:

  • Confirm interactions using alternative methods (yeast two-hybrid, proximity ligation assay)

  • Generate truncation mutants to map interaction domains

  • Use competition assays with recombinant proteins to test direct interactions

The extraction conditions dramatically affect co-IP outcomes in yeast. Cell lysis conditions must be gentle enough to preserve protein-protein interactions while ensuring efficient extraction from the yeast cell. The lysis buffer composition should be tailored to the specific characteristics of YKL131W and its potential interaction partners .

How can I use YKL131W antibody to study protein dynamics and modifications during cellular stress responses?

Studying protein dynamics during stress responses requires time-course approaches:

• Experimental design:

  • Establish baseline expression in normal conditions

  • Apply relevant stress (heat shock, oxidative stress, nutrient limitation)

  • Collect samples at multiple timepoints (0, 15, 30, 60, 120 minutes)

  • Process all samples simultaneously to minimize technical variation

• Modification-specific detection:

  • For phosphorylation: Use Phos-tag gels or phospho-specific antibodies

  • For ubiquitination: Include deubiquitinase inhibitors in lysis buffer

  • For SUMOylation: Use SUMO-specific antibodies for co-IP

  • For acetylation: Include deacetylase inhibitors during sample preparation

• Quantification approaches:

  • Use internal loading controls (e.g., Pgk1, actin)

  • Implement fluorescent secondary antibodies for quantitative western blotting

  • Consider mass spectrometry for site-specific modification analysis

• Subcellular localization changes:

  • Perform fractionation studies at each timepoint

  • Use live-cell imaging with fluorescently tagged proteins

  • Implement immunofluorescence microscopy with the YKL131W antibody

When analyzing post-translational modifications, including phosphatase and deubiquitinase inhibitors in lysis buffers is crucial. For stress response studies, the timing of sample collection is critical, as many modifications are transient. Using antibodies that specifically recognize modified forms of YKL131W provides the most direct approach, though these are often more challenging to develop and validate .

How does YKL131W antibody detection compare with epitope tagging approaches in yeast?

Comparing native antibody detection with epitope tagging reveals distinct advantages and limitations:

What are the relative merits of RNA-based versus antibody-based methods for studying YKL131W expression?

RNA and protein detection methods provide complementary information:

The correlation between mRNA and protein levels in yeast can be poor for many genes due to post-transcriptional regulation. For comprehensive studies of YKL131W, combining RNA-based methods (for transcriptional regulation) with antibody-based methods (for protein abundance and localization) provides the most complete picture. This integrated approach is particularly valuable when studying responses to environmental conditions, where post-transcriptional regulation may play a significant role .

How do different antibody characterization approaches complement each other for comprehensive YKL131W research?

A multi-method antibody characterization strategy provides comprehensive insights:

• Structural characterization:

  • X-ray crystallography or cryo-EM: Provides atomic-resolution structure of antibody-antigen complexes

  • Hydrogen-deuterium exchange mass spectrometry: Maps epitope binding regions

  • Surface plasmon resonance: Measures binding kinetics and affinity

• Functional characterization:

  • Neutralization assays: Assess antibody's ability to block protein function

  • Binding interference assays: Determine if antibody affects protein-protein interactions

  • Enzyme inhibition assays: Measure impact on enzymatic activity

• Epitope mapping:

  • Peptide arrays: Identify linear epitopes

  • Alanine scanning mutagenesis: Identify critical binding residues

  • Competition assays: Determine if antibodies recognize overlapping epitopes

• In vivo characterization:

  • Knockout validation: Confirm specificity using genetic knockouts

  • Immunoprecipitation-mass spectrometry: Identify binding partners

  • In vivo imaging: Assess antibody localization and target engagement

Similar to the comprehensive characterization of neutralizing antibodies like CSW1-1805 described in the search results, a thorough characterization of YKL131W antibodies provides critical information for experimental design. For example, knowing whether an antibody recognizes a linear or conformational epitope informs whether it will be suitable for western blotting (denatured proteins) versus immunoprecipitation (native proteins) .

What are the most critical considerations when selecting a YKL131W antibody for my specific research question?

Selecting the optimal antibody requires alignment with experimental goals:

• Application compatibility:

  • Western blot: Antibodies against linear epitopes work best

  • Immunoprecipitation: Antibodies against native conformations are essential

  • ChIP: Epitope must be accessible in crosslinked chromatin

  • Immunofluorescence: High specificity is critical to avoid background

• Technical specifications:

  • Sensitivity: Determine the detection limit required for your application

  • Specificity: Assess cross-reactivity with related yeast proteins

  • Reproducibility: Consider lot-to-lot variation, especially for polyclonal antibodies

  • Host species: Choose based on compatibility with other antibodies in multiplexed assays

• Experimental validation:

  • Published literature: Review published validations in similar applications

  • Vendor validation data: Assess comprehensiveness of validation experiments

  • Independent validation: Plan to perform your own validation with appropriate controls

• Practical considerations:

  • Amount needed: Calculate based on planned experiments

  • Cost-effectiveness: Balance quality with budget constraints

  • Storage requirements: Assess stability and storage conditions

  • Technical support: Consider vendor expertise with yeast systems

For critical experiments, comparing multiple antibodies from different vendors is recommended. When studying proteins with multiple isoforms or modifications, selecting antibodies that can distinguish between these forms becomes essential. Careful antibody selection at the outset saves significant time and resources in the long run .

How might future antibody technologies enhance YKL131W research?

Emerging antibody technologies offer promising advancements:

• Next-generation recombinant antibodies:

  • Single-chain variable fragments (scFvs) with improved tissue penetration

  • Bispecific antibodies targeting YKL131W and interaction partners simultaneously

  • Intrabodies designed for expression within yeast cells for live monitoring

• Engineered detection systems:

  • Nanobodies with enhanced stability and reduced size for better access to sterically hindered epitopes

  • Split-protein complementation systems for detecting protein-protein interactions in live cells

  • Proximity-dependent labeling coupled with antibody recognition

• Advanced screening platforms:

  • Phage display libraries for identifying high-affinity binding fragments

  • Yeast surface display for rapid antibody evolution and optimization

  • Computational design of antibodies with predetermined binding properties

• Integrative approaches:

  • Antibody-guided CRISPR systems for targeted genomic modification

  • Antibody-based proteomics for system-wide protein interaction mapping

  • Spatially-resolved antibody detection for subcellular localization studies

These emerging technologies will allow researchers to address previously intractable questions about YKL131W function and regulation. For example, intracellularly expressed nanobodies could enable real-time tracking of YKL131W dynamics during the cell cycle or stress responses, providing insights not possible with conventional antibodies that require cell fixation .

What consensus protocols exist for standardizing YKL131W antibody validation across different research groups?

Standardization efforts focus on comprehensive validation criteria:

• Minimum information standards:

  • Identity: Complete antibody identification information (catalog number, lot, clone)

  • Specificity: Evidence from knockout/knockdown controls

  • Reproducibility: Demonstration across multiple experimental replicates

  • Application validation: Evidence for each claimed application

• Five pillars of antibody validation:

  • Genetic strategy: Testing in YKL131W knockout strains

  • Orthogonal strategy: Correlation with orthogonal detection methods (MS, RNA)

  • Independent antibody strategy: Confirmation with antibodies targeting different epitopes

  • Expression of tagged proteins: Correlation with epitope-tagged protein detection

  • Immunocapture followed by mass spectrometry: Confirmation of target identity

• Reporting standards:

  • Detailed methods section including antibody dilution, incubation conditions

  • Inclusion of all controls in published figures

  • Sharing of detailed protocols through repositories

  • Disclosure of failed conditions alongside successful ones

• Community resources:

  • Antibody validation databases

  • Protocol repositories with standardized procedures

  • Reference materials for antibody comparison